Literature DB >> 35952688

Radiation Therapy for Soft Tissue Sarcoma: Indications, Timing, Benefits, and Consequences.

Kilian E Salerno1.   

Abstract

Radiation therapy is an integral component of local management with oncologic resection for soft tissue sarcoma. Radiotherapy is indicated in patients at an increased risk of local recurrence so that improved local control may be achieved. Sequencing of radiotherapy and resection should be determined by multidisciplinary input before treatment initiation. For most patients, preoperative delivery of radiation therapy is preferred. In patients initially thought to be at low risk for local recurrence and found to have unexpected adverse pathologic features at resection, postoperative radiation therapy is indicated. The use of radiation therapy for retroperitoneal sarcoma is controversial; when used, preoperative delivery of radiation is recommended. Published by Elsevier Inc.

Entities:  

Keywords:  Limb-sparing surgery; Local control; Local recurrence; Radiation therapy; Retroperitoneal sarcoma; Soft tissue sarcoma

Mesh:

Year:  2022        PMID: 35952688      PMCID: PMC9372474          DOI: 10.1016/j.suc.2022.04.001

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   3.537


  68 in total

1.  Role of post-operative radiation boost for soft tissue sarcomas with positive margins following pre-operative radiation and surgery.

Authors:  Elizabeth Pan; Saveli I Goldberg; Yen-Lin Chen; Christine Giraud; Jason L Hornick; Gunnlaugur P Nielsen; Francis J Hornicek; Chandrajit P Raut; Thomas F DeLaney; Elizabeth H Baldini
Journal:  J Surg Oncol       Date:  2014-08-11       Impact factor: 3.454

2.  Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities.

Authors:  P W Pisters; D H Leung; J Woodruff; W Shi; M F Brennan
Journal:  J Clin Oncol       Date:  1996-05       Impact factor: 44.544

3.  Combined Modality Management of Retroperitoneal Sarcomas: A Single-Institution Series of 121 Patients.

Authors:  Andrew J Bishop; Gunar K Zagars; Keila E Torres; Kelly K Hunt; Janice N Cormier; Barry W Feig; B Ashleigh Guadagnolo
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-05-02       Impact factor: 7.038

4.  Dose--effect relationships for femoral fractures after multimodality limb-sparing therapy of soft-tissue sarcomas of the proximal lower extremity.

Authors:  Daniel Pak; Karen A Vineberg; Kent A Griffith; Aaron Sabolch; Rashmi Chugh; Edgar Ben-Josef; Janet Sybil Biermann; Mary Feng
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-11-16       Impact factor: 7.038

5.  Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial.

Authors:  Brian O'Sullivan; Aileen M Davis; Robert Turcotte; Robert Bell; Charles Catton; Pierre Chabot; Jay Wunder; Rita Kandel; Karen Goddard; Anna Sadura; Joseph Pater; Benny Zee
Journal:  Lancet       Date:  2002-06-29       Impact factor: 79.321

6.  Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapy.

Authors:  B Ashleigh Guadagnolo; Gunar K Zagars; Matthew T Ballo; Shreyaskumar R Patel; Valerae O Lewis; Robert S Benjamin; Raphael E Pollock
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-24       Impact factor: 7.038

7.  Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma: a comparison with other soft tissue sarcomas.

Authors:  Peter W M Chung; Benjamin M Deheshi; Peter C Ferguson; Jay S Wunder; Anthony M Griffin; Charles N Catton; Robert S Bell; Lawrence M White; Rita A Kandel; Brian O'Sullivan
Journal:  Cancer       Date:  2009-07-15       Impact factor: 6.860

8.  Preoperative hypofractionated radiotherapy in the treatment of localized soft tissue sarcomas.

Authors:  H Koseła-Paterczyk; M Szacht; T Morysiński; I Ługowska; W Dziewirski; S Falkowski; M Zdzienicki; A Pieńkowski; K Szamotulska; T Switaj; P Rutkowski
Journal:  Eur J Surg Oncol       Date:  2014-09-20       Impact factor: 4.424

9.  Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomas.

Authors:  Thomas F DeLaney; Yen-Lin Chen; Elizabeth H Baldini; Dian Wang; Judith Adams; Shea B Hickey; Beow Y Yeap; Stephen M Hahn; Karen De Amorim Bernstein; G Petur Nielsen; Edwin Choy; John T Mullen; Sam S Yoon
Journal:  Adv Radiat Oncol       Date:  2017-01-04

10.  Radiation Therapy for Treatment of Soft Tissue Sarcoma in Adults: Executive Summary of an ASTRO Clinical Practice Guideline.

Authors:  Kilian E Salerno; Kaled M Alektiar; Elizabeth H Baldini; Manpreet Bedi; Andrew J Bishop; Lisa Bradfield; Peter Chung; Thomas F DeLaney; Andrew Folpe; John M Kane; X Allen Li; Ivy Petersen; John Powell; Michael Stolten; Steven Thorpe; Jonathan C Trent; Maria Voermans; B Ashleigh Guadagnolo
Journal:  Pract Radiat Oncol       Date:  2021-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.